BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 31179301)

  • 1. Neurologic impairment in Wilson disease.
    Dusek P; Litwin T; Członkowska A
    Ann Transl Med; 2019 Apr; 7(Suppl 2):S64. PubMed ID: 31179301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilson disease.
    Kitzberger R; Madl C; Ferenci P
    Metab Brain Dis; 2005 Dec; 20(4):295-302. PubMed ID: 16382340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic treatment of neurologic symptoms in Wilson disease.
    Litwin T; Dušek P; Członkowska A
    Handb Clin Neurol; 2017; 142():211-223. PubMed ID: 28433105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study.
    Dusek P; Bahn E; Litwin T; Jabłonka-Salach K; Łuciuk A; Huelnhagen T; Madai VI; Dieringer MA; Bulska E; Knauth M; Niendorf T; Sobesky J; Paul F; Schneider SA; Czlonkowska A; Brück W; Wegner C; Wuerfel J
    Neuropathol Appl Neurobiol; 2017 Oct; 43(6):514-532. PubMed ID: 27543917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilson disease: brain pathology.
    Poujois A; Mikol J; Woimant F
    Handb Clin Neurol; 2017; 142():77-89. PubMed ID: 28433113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does brain degeneration in Wilson disease involve not only copper but also iron accumulation?
    Skowrońska M; Litwin T; Dzieżyc K; Wierzchowska A; Członkowska A
    Neurol Neurochir Pol; 2013; 47(6):542-6. PubMed ID: 24374999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease.
    Walter U; Krolikowski K; Tarnacka B; Benecke R; Czlonkowska A; Dressler D
    Neurology; 2005 May; 64(10):1726-32. PubMed ID: 15911799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wilson disease: neurologic features.
    Członkowska A; Litwin T; Chabik G
    Handb Clin Neurol; 2017; 142():101-119. PubMed ID: 28433096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic features of Wilson disease.
    Boga S; Ala A; Schilsky ML
    Handb Clin Neurol; 2017; 142():91-99. PubMed ID: 28433114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics of the Wilson disease carrier].
    Zhou XX; He RX; Pu XY; Li XH; Qin HL; Huang HW; Liang XL
    Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(11):806-811. PubMed ID: 30893721
    [No Abstract]   [Full Text] [Related]  

  • 11. [Wilson disease: an update].
    Seo JK
    Korean J Hepatol; 2006 Sep; 12(3):333-63. PubMed ID: 16998287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics of patients with delayed hepatolenticular degeneration].
    Zhou XX; Qin HL; He RX; Chen DB; Wu C; Feng L; Li XH; Liang XL
    Zhonghua Nei Ke Za Zhi; 2019 Jul; 58(7):501-507. PubMed ID: 31269566
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathogenesis of Wilson disease.
    Scheiber IF; Brůha R; Dušek P
    Handb Clin Neurol; 2017; 142():43-55. PubMed ID: 28433109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation as a rescue therapy for severe neurologic forms of Wilson disease.
    Poujois A; Sobesky R; Meissner WG; Brunet AS; Broussolle E; Laurencin C; Lion-François L; Guillaud O; Lachaux A; Maillot F; Belin J; Salamé E; Vanlemmens C; Heyd B; Bellesme C; Habes D; Bureau C; Ory-Magne F; Chaine P; Trocello JM; Cherqui D; Samuel D; de Ledinghen V; Duclos-Vallée JC; Woimant F
    Neurology; 2020 May; 94(21):e2189-e2202. PubMed ID: 32398357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wilson disease and related copper disorders.
    Lorincz MT
    Handb Clin Neurol; 2018; 147():279-292. PubMed ID: 29325617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Liver Transplant on Neurologic Manifestations and Brain Magnetic Resonance Imaging Findings in Wilson Disease.
    Öcal R; Ayvazoğlu Soy EH; Benli S; Dönmez F; Ağıldere M; Öcal S; Haberal M
    Exp Clin Transplant; 2020 Jan; 18(Suppl 1):84-87. PubMed ID: 32008504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features, MRI brain, and MRS abnormalities of drug-naïve neurologic Wilson's disease.
    Pulai S; Biswas A; Roy A; Guin DS; Pandit A; Gangopadhyay G; Ghorai PK; Sarkhel S; Senapati AK
    Neurol India; 2014; 62(2):153-8. PubMed ID: 24823724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of oxidative stress, cytokines and glutamate in Wilson disease and their asymptomatic siblings.
    Kalita J; Kumar V; Misra UK; Ranjan A; Khan H; Konwar R
    J Neuroimmunol; 2014 Sep; 274(1-2):141-8. PubMed ID: 25002079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The diagnostic value and limits of diagnostic parameters for Wilson's disease].
    Yang X
    Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):881-885. PubMed ID: 29325287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilson's disease tremor is associated with magnetic resonance imaging lesions in basal ganglia structures.
    Südmeyer M; Saleh A; Wojtecki L; Cohnen M; Gross J; Ploner M; Hefter H; Timmermann L; Schnitzler A
    Mov Disord; 2006 Dec; 21(12):2134-9. PubMed ID: 17044091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.